FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to molecular biology, biochemistry, immunology and gene engineering. What is presented is a composition for specifying a variety of CDR3 sequences of TCRB or IGH in a sample.
EFFECT: invention can be used for assessing the patient's adaptive immune system in medicine.
36 cl, 14 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF MEASUREMENT AND CALIBRATION OF SYSTEMATIC MISTAKE OF AMPLIFICATION IN MULTIPLEX PCR-REACTIONS | 2013 |
|
RU2631797C2 |
AFFINE MOLECULE-OLIGONUCLEOTIDE CONJUGATES AND THEIR APPLICATIONS | 2017 |
|
RU2763554C2 |
Vβ-Dβ-Jβ OLIGONUCLEOTIDE OF T-CELL RECEPTOR, PAIR PRIMERS, OLIGONUCLEOTIDE PROBE, METHOD FOR DETECTION OF MBP83-99Vβ13.1 CLONE PF T-CELLS, ESPRESSING LGRAGLTY MOTIVE OF T-CELL RECEPTOR, KIT, METHOD FOR TREATMENT OF AUTOIMMUNE DECEASE AND METHOD FOR MONITORING THEREOF | 2000 |
|
RU2251552C2 |
GENETICALLY MODIFIED T CELL RECEPTOR MICE | 2012 |
|
RU2661106C2 |
METHOD FOR DETERMINING MARKERS OF PRESENCE OF TUMOR T-LYMPHOBLASTS | 2016 |
|
RU2674994C2 |
AFFINITY CONJUGATES - OLIGONUCLEOTIDE AND THEIR APPLICATIONS | 2016 |
|
RU2778754C2 |
METHOD OF MEASURING CHANGE IN INDIVIDUAL'S IMMUNE REPERTOIRE | 2016 |
|
RU2714752C2 |
HIGH THROUGHPUT SEQUENCING OF POLYNUCLEOTIDE LIBRARIES AND TRANSCRIPTOME ANALYSIS | 2018 |
|
RU2790291C2 |
HUMANIZED T-CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS | 2016 |
|
RU2732628C2 |
GENETICALLY MODIFIED MICE FOR T-CELL RECEPTOR | 2012 |
|
RU2797272C1 |
Authors
Dates
2015-01-10—Published
2010-06-04—Filed